Inflexion is pleased to announce that it has sold its investment in Kynetec, a leader in agricultural and animal health market research, data and insights, to US-based Paine Schwartz Partners.  The transaction follows a nearly five-year partnership and delivers a strong return, marking the fifth exit for Inflexion funds over the past 9 months.

In 2016 Inflexion carved Kynetec out of its listed German parent GfK. The company subsequently embarked on an ambitious growth journey, with significant investment into technology and acquisitive-led growth, including the transformational purchase of Germany-based Kleffmann Group. The successful partnership with Inflexion strengthened the firm’s operations in North and South America, Asia and Europe, resulting in a global business operating in 30 countries.